Imunon, Inc. (IMNN)

Imunon Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0	0.5	0.5	0.5	0.5
Gross Profit	0	0	0.5	0.5	0.5	0.5
Selling, General & Admin	8.4	9.74	13.69	10.89	7.64	8
Research & Development	11.96	11.29	11.73	10.62	11.34	13.07
Operating Expenses	20.36	21.03	25.42	21.51	18.99	21.07
Operating Income	-20.36	-21.03	-24.92	-21.01	-18.49	-20.57
Interest Expense / Income	0.04	0.2	5.03	0.57	1.29	1.39
Other Expense / Income	-0.26	-0.43	7.52	0.58	3.55	-3.29
Pretax Income	-20.13	-20.8	-37.47	-22.15	-23.33	-18.67
Income Tax	-1.28	-1.28	-1.57	-1.38	-1.85	-1.82
Net Income	-18.85	-19.51	-35.9	-20.77	-21.48	-16.85
Shares Outstanding (Basic)	9	9	7	5	2	1
Shares Outstanding (Diluted)	9	9	7	5	2	1
Shares Change	13.50%	26.63%	31.62%	154.70%	46.39%	24.17%
EPS (Basic)	-2.02	-2.16	-5.03	-3.83	-10.08	-11.55
EPS (Diluted)	-2.02	-2.16	-5.03	-3.83	-10.08	-11.55
Free Cash Flow	-21.22	-19.47	-23.36	-16.54	-15.64	-20.61
Free Cash Flow Per Share	-2.26	-2.15	-3.27	-3.05	-7.34	-14.16
Gross Margin	-	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-	-4984.31%	-4201.44%	-3697.28%	-4113.09%
Profit Margin	-	-	-7179.65%	-4153.85%	-4296.71%	-3370.31%
Free Cash Flow Margin	-	-	-4672.94%	-3307.04%	-3127.55%	-4121.63%
EBITDA	-19.39	-19.88	-31.71	-20.88	-21.3	-16.55
EBITDA Margin	-	-	-6341.00%	-4175.98%	-4259.10%	-3310.59%
Depreciation & Amortization	0.71	0.72	0.73	0.7	0.74	0.72
EBIT	-20.1	-20.6	-32.44	-21.58	-22.04	-17.27
EBIT Margin	-	-	-6487.33%	-4316.56%	-4407.41%	-3454.92%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).